OrthoPediatrics investors report 3.2% ownership stake

Rhea-AI Filing Summary

Integrated Core Strategies (US) LLC and related Millennium entities reported beneficial ownership of OrthoPediatrics Corp. common stock on a Schedule 13G/A. Integrated Core Strategies (US) LLC reports 811,042 shares, representing 3.2% of the common stock with shared voting and dispositive power only.

Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander each report beneficial ownership of 816,830 shares, also equal to 3.2% of the class, with no sole voting or dispositive power. The filers state they collectively own 5 percent or less of the class and clarify that their control relationships do not, by themselves, constitute an admission of beneficial ownership. A joint filing agreement among the four reporting persons is included.

Key Figures

Integrated Core Strategies beneficial ownership: 811,042 shares Millennium entities beneficial ownership: 816,830 shares Ownership percentage per reporting person: 3.2% +3 more

6 metrics

Integrated Core Strategies beneficial ownership 811,042 shares Shared voting and dispositive power over OrthoPediatrics common stock

Millennium entities beneficial ownership 816,830 shares Reported by Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander

Ownership percentage per reporting person 3.2% Percent of OrthoPediatrics common stock class reported on each cover page

Ownership threshold noted 5 percent or less Item 5 indicates ownership of 5 percent or less of the class

Event date for ownership report 06/30/2026 Date associated with the reported OrthoPediatrics ownership position

Joint filing agreement date July 14, 2026 Date of Joint Filing Agreement among the four reporting persons

Key Terms

Schedule 13G/A, beneficial ownership, shared voting power, shared dispositive power, +1 more

5 terms

Schedule 13G/A regulatory

"This is a Schedule 13G/A (Amendment No. 1) reporting beneficial ownership."

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

beneficial ownership financial

"Item 4. | Ownership (a) | Amount beneficially owned: See response to Item 9"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

shared voting power financial

"6 | Shared Voting Power 811,042.00 7 | Sole Dispositive Power 0.00"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

shared dispositive power financial

"8 | Shared Dispositive Power 816,830.00 9 816,830.00"

Joint Filing Agreement regulatory

"Exhibit I: Joint Filing Agreement, dated as of July 14, 2026"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What ownership stake in OrthoPediatrics Corp. (KIDS) did Integrated Core Strategies report?

Integrated Core Strategies (US) LLC reported 811,042 shares of OrthoPediatrics common stock, representing 3.2% of the outstanding class, held with shared voting and shared dispositive power and no sole power over the shares.

How many OrthoPediatrics (KIDS) shares do the Millennium entities and Israel A. Englander report?

Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander each report beneficial ownership of 816,830 shares of OrthoPediatrics common stock, equal to 3.2% of the class, all with shared voting and dispositive power only.

Do the reporting persons in this OrthoPediatrics (KIDS) Schedule 13G/A own more than 5%?

No. The filing specifies Ownership of 5 percent or less of a class, and each reporting person’s beneficial ownership is reported as 3.2% of OrthoPediatrics’ common stock, below the 5% threshold.

What type of filing is this for OrthoPediatrics (KIDS) and what does it indicate?

This is a Schedule 13G/A (Amendment No. 1), indicating updated passive beneficial ownership information. It shows several Millennium-related entities and Israel A. Englander collectively reporting up to 816,830 shares with shared control characteristics.

Who are the reporting persons in the OrthoPediatrics (KIDS) Schedule 13G/A amendment?

The reporting persons are Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander, all providing a joint ownership report for OrthoPediatrics common stock.

What voting and dispositive powers are reported over OrthoPediatrics (KIDS) shares?

Each reporting person reports 0 shares with sole voting or dispositive power and either 811,042 or 816,830 shares with shared voting and shared dispositive power, reflecting coordinated control rather than individual sole authority.

When was the joint filing agreement for the OrthoPediatrics (KIDS) Schedule 13G/A dated?

The joint filing agreement among Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander is dated July 14, 2026, the same date as the signatures on the ownership report.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/15/2026 - 07:09 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

OrthoPediatrics Corp.

(Name of Issuer)

Common Stock, par value $0.00025 per share

(Title of Class of Securities)

68752L100

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 68752L100

1

Names of Reporting Persons

Integrated Core Strategies (US) LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 811,042.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 811,042.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

811,042.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

3.2 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP Number(s): 68752L100

1

Names of Reporting Persons

Millennium Management LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 816,830.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 816,830.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

816,830.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

3.2 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP Number(s): 68752L100

1

Names of Reporting Persons

Millennium Group Management LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 816,830.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 816,830.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

816,830.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

3.2 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP Number(s): 68752L100

1

Names of Reporting Persons

Israel A. Englander

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 816,830.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 816,830.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

816,830.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

3.2 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: OrthoPediatrics Corp.
(b)	Address of issuer's principal executive offices: 2850 Frontier Drive, Warsaw, Indiana 46582
Item 2.
(a)	Name of person filing: Integrated Core Strategies (US) LLC Millennium Management LLC Millennium Group Management LLC Israel A. Englander
(b)	Address or principal business office or, if none, residence: Integrated Core Strategies (US) LLC c/o Millennium Management LLC 399 Park Avenue New York, New York 10022 Millennium Management LLC 399 Park Avenue New York, New York 10022 Millennium Group Management LLC 399 Park Avenue New York, New York 10022 Israel A. Englander c/o Millennium Management LLC 399 Park Avenue New York, New York 10022
(c)	Citizenship: Integrated Core Strategies (US) LLC - Delaware Millennium Management LLC - Delaware Millennium Group Management LLC - Delaware Israel A. Englander - United States
(d)	Title of class of securities: Common Stock, par value $0.00025 per share
(e)	CUSIP No.: 68752L100
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See response to Item 9 on each cover page.
(b)	Percent of class: See response to Item 11 on each cover page.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See response to Item 5 on each cover page.
	(ii) Shared power to vote or to direct the vote: See response to Item 6 on each cover page.
	(iii) Sole power to dispose or to direct the disposition of: See response to Item 7 on each cover page.
	(iv) Shared power to dispose or to direct the disposition of: See response to Item 8 on each cover page. The securities disclosed herein as potentially beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Mr. Englander are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers that may be controlled by Millennium Group Management LLC (the managing member of Millennium Management LLC) and Mr. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). The foregoing should not be construed in and of itself as an admission by Millennium Management LLC, Millennium Group Management LLC or Mr. Englander as to beneficial ownership of the securities held by such entities.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Integrated Core Strategies (US) LLC

Signature:	/s/ Gil Raviv
Name/Title:	Gil Raviv, Global General Counsel
Date:	07/14/2026

Millennium Management LLC

Signature:	/s/ Gil Raviv
Name/Title:	Gil Raviv, Global General Counsel
Date:	07/14/2026

Millennium Group Management LLC

Signature:	/s/ Gil Raviv
Name/Title:	Gil Raviv, Global General Counsel
Date:	07/14/2026

Israel A. Englander

Signature:	/s/ Israel A. Englander
Name/Title:	Israel A. Englander
Date:	07/14/2026

Comments accompanying signature: ** INTEGRATED CORE STRATEGIES (US) LLC By: Integrated Holding Group LP, its Managing Member By: Millennium Management LLC, its General Partner

Exhibit Information

Exhibit I: Joint Filing Agreement, dated as of July 14, 2026, by and among Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.